<DOC>
	<DOCNO>NCT00101452</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness s-adenosyl-l-methionine ( SAMe ) treat major depression .</brief_summary>
	<brief_title>Safety Effectiveness S-adenosyl-l-methionine ( SAMe ) Treatment Major Depression</brief_title>
	<detailed_description>SAMe substance naturally produce body also sell over-the-counter drug . Although SAMe yet approve treat depression , evidence suggest antidepressant property . This study determine whether SAMe safe effective treat major depression . This study last 24 week . Participants randomly assign receive either antidepressant escitalopram , SAMe , placebo 12 week . Participants respond treatment end 12 week stay regimen additional 12 week . Participants respond treatment enter open treatment phase receive SAMe escitalopram 12 week . Depression scale self-report questionnaire use assess participant . All participant receive 3 month follow-up care , include free medication clinic visit necessary .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Diagnosis major depression Score 25 high Inventory Depressive Symptomatology ( IDSC ) scale Score high 2 Clinical Global Impression Improvement ( CGI ) scale Willing use acceptable method contraception Suicidal homicidal Unstable illness , include cardiovascular , hepatic , renal , respiratory , endocrine , neurological , hematological disease . Any following mental condition : organic mental disorder ; schizophrenia ; delusional disorder ; psychotic disorder ; bipolar disorder ; recent bereavement ; severe borderline antisocial personality disorder ; panic disorder ; obsessive compulsive disorder Substance abuse , include alcohol abuse , within 6 month prior study entry Uncontrolled seizure disorder , seizure disorder control psychotropic anticonvulsant Psychotic feature Current use psychotropic drug Hypothyroidism Have take 6 week either escitalopram SAMe current depressive episode Previous intolerance SAMe escitalopram Investigational psychotropic drug within 1 year prior study entry Have receive two antidepressant therapy adequate dos duration fail respond Have receive depressionfocused psychotherapy Bleeding tissue disorder , low platelet count , history GI bleeding , use medication alter bleed risk Longterm aspirin use Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Depression</keyword>
	<keyword>Antidepressive Agents</keyword>
	<keyword>Complementary Therapies</keyword>
</DOC>